A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema

DW Chun, JS Heier, TM Topping, JS Duker, JM Bankert - Ophthalmology, 2006 - Elsevier
OBJECTIVE: To evaluate the biologic activity of multiple intravitreal injections of ranibizumab
in patients with center-involving clinically significant diabetic macular edema (DME) and to …

Receptor tyrosine kinase signaling and targeting in glioblastoma multiforme

M Tilak, J Holborn, LA New, J Lalonde… - International Journal of …, 2021 - mdpi.com
Glioblastoma multiforme (GBM) is amongst the deadliest of human cancers, with a median
survival rate of just over one year following diagnosis. Characterized by rapid proliferation …

1, 3, 4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

S Bajaj, V Asati, J Singh, PP Roy - European journal of medicinal chemistry, 2015 - Elsevier
Abstract Five member heterocyclic 1, 3, 4-oxadiazole nucleus find unique place in medicinal
chemistry and plays significant role in producing anticancer activity. The small and simple 1 …

VEGF expression in pancreatic cancer and other malignancies: a review of the literature

MI Costache, M Ioana, S Iordache, D Ene… - Romanian journal of …, 2015 - sciendo.com
Angiogenesis is a crucial event for tumor growth and it is regulated predominantly by several
different growth factors. Vascular endothelial growth factor protein family (VEGF) and its …

Vascular endothelial growth factor and diabetic complications

B Wirostko, TY Wong, R Simó - Progress in retinal and eye research, 2008 - Elsevier
Intraocular delivery of anti-vascular endothelial growth factor (VEGF) therapies is now used
widely to treat age-related macular degeneration, and is currently undergoing evaluation in …

Structural basis for vascular endothelial growth factor receptor activation and implications for disease therapy

F Shaik, GA Cuthbert, S Homer-Vanniasinkam… - Biomolecules, 2020 - mdpi.com
Vascular endothelial growth factors (VEGFs) bind to membrane receptors on a wide variety
of cells to regulate diverse biological responses. The VEGF-A family member promotes …

Molecular and functional diversity of vascular endothelial growth factors

Y Yamazaki, T Morita - Molecular diversity, 2006 - Springer
Members of the vascular endothelial growth factor (VEGF) family are crucial regulators of
neovascularization and are classified as cystine knot growth factors that specifically bind …

Onset and progression of human osteoarthritis—Can growth factors, inflammatory cytokines, or differential miRNA expression concomitantly induce proliferation, ECM …

KA Boehme, B Rolauffs - International journal of molecular sciences, 2018 - mdpi.com
Osteoarthritis (OA) is a degenerative whole joint disease, for which no preventative or
therapeutic biological interventions are available. This is likely due to the fact that OA …

Cyclic stretch, reactive oxygen species, and vascular remodeling

KG Birukov - Antioxidants & redox signaling, 2009 - liebertpub.com
Blood vessels respond to changes in mechanical load from circulating blood in the form of
shear stress and mechanical strain as the result of heart propulsions by changes in …

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use

FTH Wu, MO Stefanini, FM Gabhann… - Journal of cellular …, 2010 - Wiley Online Library
Introduction‐Angiogenesis in physiology and pathology‐Angiogenesis in current medicine‐
VEGF ligand and receptor system: where does sVEGFR1 fit?‐Ligands: the human VEGF …